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In the optic nerve, oligodendrocytes maintain axonal
function by supplying lactate as an energy substrate.
Here, we report that, in acute brain slices of the
mouse corpus callosum, exogenous glucose depri-
vation (EGD) abolished compound action potentials
(CAPs), which neither lactate nor pyruvate could
prevent. Loading an oligodendrocyte with 20 mM
glucose using a patch pipette prevented EGD-medi-
ated CAP reduction in about 70% of experiments.
Loading oligodendrocytes with lactate rescued
CAPs less efficiently than glucose. In mice lacking
connexin 47, oligodendrocyte filling with glucose
did not prevent CAP loss, emphasizing the impor-
tance of glial networks for axonal energy supply.
Compared with the optic nerve, the astrocyte
network in the corpus callosum was less dense,
and loading astrocytes with glucose did not prevent
CAP loss during EGD.We suggest that callosal oligo-
dendrocyte networks provide energy to sustain
axonal function predominantly by glucose delivery,
and mechanisms of metabolic support vary across
different white matter regions.
INTRODUCTION
In white matter, oligodendrocytes are instrumental to fuel
axonal activity, and the optic nerve has served as a convenient
model to study the mechanism of this cellular interaction (Mor-
rison et al., 2013). Metabolites and signaling molecules can
pass from the oligodendrocyte soma through cytoplasm-rich
myelinic channels in the compacted myelin to the innermost
tips of the oligodendrocyte process enwrapping an axon. Evi-
dence for axon-oligodendrocyte metabolic coupling initially
came from studies of optic nerve explants that were subjected
to glucose deprivation (F€unfschilling et al., 2012; Lee et al.,
2012; Morrison et al., 2013; Simons and Nave, 2015). LactateCell Re
This is an open access article undis considered to be the energy metabolite delivered by oligo-
dendrocytes. Indeed, compound action potentials (CAPs) can
be evoked in acutely isolated optic nerve preparations and
can persist for several hours but rapidly fail under aglycemic
conditions. This failure can be effectively prevented by perfu-
sion of L-lactate (Brown et al., 2003). On the basis of these
studies, it has been proposed that axons are at least partly
powered by lactate (or pyruvate) provided by oligodendrocytes.
Lactate is released into the periaxonal space by the monocar-
boxylate transporter 1 (MCT1), which is strongly expressed by
oligodendrocytes (F€unfschilling et al., 2012; Lee et al., 2012).
Lactate can then be taken up by axons via the neuronal isoform
MCT2 for mitochondrial ATP production. Recently, Saab et al.
(2016) demonstrated that NMDA receptors on oligodendro-
cytes play a key role in controlling the metabolic cooperation
between oligodendrocytes and axons. In the optic nerve,
NMDA receptor activation in response to glutamate release
increases trafficking of glucose transporter GLUT1 to the oligo-
dendrocyte membrane, thus sustaining glucose import to oli-
godendrocytes for glycolysis and downstream transfer of
lactate to axons. This mechanism might be important in dis-
eases linked to energy deprivation (e.g., white matter
ischemia).
Intact gap junctional coupling among glial cells is a prereq-
uisite for myelin maintenance and axonal function (Tress et al.,
2011, 2012). According to the current concept, astrocytes
transfer energy substrates from the vasculature, convert it to
lactate, and pass it to oligodendrocytes via gap junctions
(Nave and Werner, 2014). It is also conceivable that astrocytes
directly fuel axons, as their processes protrude into nodes of
Ranvier. Gap junctions are integral membrane structures
consisting of connexins, which allow diffusion of ions,
signaling molecules, and metabolites of up to 1 kDa, including
glucose or lactate. In the corpus callosum, oligodendrocytes
and astrocytes exhibit panglial coupling via connexin isoforms
Cx30 and Cx43, expressed by astrocytes, and Cx32 and
Cx47, expressed by oligodendrocytes. Cx47 ablation com-
pletely abolishes coupling of oligodendrocytes to astrocytes
and results in smaller oligodendrocyte networks (Maglione
et al., 2010).ports 22, 2383–2394, February 27, 2018 ª 2018 The Authors. 2383
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. Exogeneous Glucose Deprivation Leads to Rapid Decline of Axonal Activity in the Corpus Callosum
(A) Overview of a frontal brain slice used for electrophysiological recordings. The inset shows the position of the field (Field) and stimulation (Stim) electrodes.
Evoked CAPs were measured by the field electrode. CC, corpus callosum; Cx, cortex.
(B) Representative recordings of CAPs to illustrate the time course of CAP decline during 55min (at room temperature) or 10min (at 36C) EGD (gluc-). The sample
traces for experiments at room temperature (top, blue) and 36C (green) show the CAPs at the beginning of the experiment (1), during EGD (2), and after glucose
was reperfused (3). The filled area (blue/green) corresponds to the area for CAP calculation. Plots at the bottom show sample traces of normalized CAP areas
during glucose deprivation and reperfusion.
(C) Representative traces for CAP progression at 36C with (green) and without (black) a 10 min EGD period. An overshoot of the CAPs is apparent after EGD
(n = 4, N = 1).
(D) Representative CAP traces (36C) in which glucose was replaced by either 20 mM L-lactate or 20 mM pyruvate during a 10 min EGD period. CAPs cannot be
maintained during glucose deprivation by equimolar amounts of lactate or pyruvate.Although the optic nerve has served as a model for most
previous studies to analyze oligodendrocyte-axonal metabolic
coupling, we have now studied another white matter structure,
the corpus callosum. As the largest white matter structure in
the brain, it connects the left and right cerebral hemispheres
and enables interhemispheric communication. In contrast to
the optic nerve, which is completely myelinated, the corpus
callosum contains only about 30%–40% of myelinated fibers
and thus exhibits a different architecture (Mack et al., 1995).
The present study was prompted by our initial observation
that the perfusion of L-lactate is not sufficient to preserve
axonal activity in the corpus callosum during exogeneous
glucose deprivation (EGD). This was in contrast to the findings
in optic nerve (Brown et al., 2003, 2005), which implies distinct
mechanisms of neuron-glia cooperation in different white mat-
ter regions. We adapted an approach originally used to inves-
tigate how astrocytes provide energy substrates to neurons in
gray matter. Rouach et al. (2008) showed that intracellular
application of glucose or lactate into hippocampal astrocytes
sustains glutamatergic synaptic transmission during exogene-
ous glucose deprivation. Here, we filled glucose or lactate into
oligodendrocytes or astrocytes in the corpus callosum and
found that the most efficient combination to maintain axonal
activity during glucose deprivation was the delivery of glucose
into oligodendrocytes.2384 Cell Reports 22, 2383–2394, February 27, 2018RESULTS
CAPs Quickly Decline under Exogenous Glucose
Deprivation, and This Decline Is Not Prevented by
Adding Lactate or Pyruvate
To monitor axonal function in the corpus callosum under normal
and aglycemic conditions, stimulation and recording electrodes
were placed in freshly prepared coronal brain slices, as shown in
Figure 1A. Twenty-five pulses at a frequency of 50 Hz were
applied every 15 s (0.5 s stimulation and 14.5 s recovery time),
and CAPs were recorded. For quantification, we determined
the area under the action potential curve (i.e., integral of ampli-
tude over time), which reflects the number of active axons and
the magnitude of the individual action potentials. CAP ampli-
tudes remained constant over recording periods of at least
45 min in continuously gassed (95% O2, 5% CO2) artificial
cerebrospinal fluid (ACSF) containing 10 mM glucose at 36C
(Figure 1C, black trace). CAPswere dependent on voltage-gated
Na+ channels, as application of tetrodotoxin (TTX) (1 mM)
completely blocked them (Figure S1). For aglycemia experi-
ments, we recorded CAPs for 5 min in normal ACSF and
subsequently changed to glucose-free ACSF for 10 min. CAP
amplitudes declined within 5 min to almost zero and remained
at this level in all experiments (n = 37) during exogenous glucose
deprivation (EGD). Upon reapplication of 10 mM glucose, CAP
amplitudes recovered to their initial value within 5 min. In most
experiments, the CAP amplitudes showed an overshoot of
110%–150% (Figure 1C, green).We also performed experiments
at room temperature to test the impact of temperature on
metabolic activity. CAP activity declined considerably more
slowly in glucose-free solution and reached a steady state close
to zero only after about 30 min. The slice was maintained in
glucose-free solution for 55 min. Upon reperfusion of glucose-
containing ACSF, CAP activity recovered to baseline within
20 min and, in contrast to recordings at 36C (green), did not
overshoot (Figure 1B, black trace).
We next tested if lactate or pyruvate can sustain CAP activity
during aglycemia, as observed in the optic nerve (Brown et al.,
2003). When we replaced 10 mM glucose with 20 mM L-lactate,
CAP activity declined as rapidly as in glucose-free solution and
recovered only by reperfusion of glucose (Figure 1D, green).
Replacement of 10 mM glucose with 20 mM pyruvate also re-
sulted in a rapid decline of CAP activity and showed recovery
only after glucose reperfusion (Figure 1D, blue trace). These
findings indicate that glucose specifically, rather than lactate or
pyruvate, is required to maintain axonal activity in the corpus
callosum in this experimental paradigm.
Loss of CAPs during EGD Can Be Prevented by Loading
Glucose into Single Oligodendrocytes
We tested whether glucose supply from oligodendrocytes could
compensate for the depletion of glucose in the ACSF. Oligoden-
drocytes in acute brain slices from PLP-GFPxhGFAP-mRFP
transgenic mice were identified by their GFP fluorescence and
astrocytes by their mRFP fluorescence (Hirrlinger et al., 2005).
An oligodendrocyte in the corpus callosum was patch-clamped
and dialyzed for 20 min with intracellular solution containing
20 mM glucose prior to the CAP recordings and the induction
of EGD. The intracellular solution also contained the fluorescent
dye Sulforhodamine B to verify successful dialysis of the cell. The
injected cells were further characterized by recording their
membrane currents at a holding potential of 70 mV and during
de- and hyperpolarizing voltage steps. The cells typically
showed some current decay during the voltage step and large
symmetrical tail currents, a characteristic feature of mature
oligodendrocytes (Berger et al., 1991) (Figure 2B). The patched
oligodendrocytes had an average input resistance of 62.59 ±
5.67 MU, a reversal potential of 64.34 ± 1.97 mV, and a
membrane capacitance of 23.09 ± 3.35 pF (n = 22, N = 17). These
properties did not significantly change in the course of the 20min
dialysis (Figure 2B), indicating that network composition was not
altered. After dialysis of an oligodendrocyte with 20mMglucose,
we measured CAP activity during EGD, as described above. In
about 70% of the experiments, the fast EGD-induced drop of
CAP activity was not seen when oligodendrocytes had been
pre-loaded with glucose, and the normalized CAP amplitude
shortly before reperfusion (at 16 min) was on average still
43% ± 8.1% of the maximum CAP amplitude (n = 14, N = 10;
includes those experiments in which the CAP value at 16 min
was stillR30% of the maximal CAP value). The averaged traces
for CAP activity during EGD in control and after dialysis of an
oligodendrocyte with glucose are shown in Figure 2A. The scat-
terplot at the bottom shows the normalized CAP amplitudes at16 min for each experiment, shortly before reperfusion with
normal ACSF. It is apparent that the extent of CAP maintenance
during EGD after oligodendrocyte loading varies, possibly
because of the size of the associated panglial network. To
control for unspecific loading effects, we used the non-metabo-
lizable sugar mannitol instead of glucose for dialysis prior to
EGD. In none of the experiments could mannitol prevent the
loss of CAPs during EGD (Figure 5B; n = 6). In conclusion,
elevated glucose in oligodendrocytes can prevent the loss of
CAPs during EGD.
Loading Single Astrocytes with Glucose Was Much Less
Effective in Preventing CAP Loss during EGD
In a similar approach as described above, we dialyzed astro-
cytes with 20 mM glucose. The astrocytes, identified by their
red fluorescent transgene expression, typically displayed an
average input resistance of 45.51 ± 10.47 MU, a reversal po-
tential of 78.67 ± 1.80 mV, and a membrane capacitance of
16.31 ± 8.90 pF (n = 4, N = 4). Similar to the oligodendrocytes,
passive membrane properties did not significantly change in
the course of the 20 min dialysis (Figure 2B). In contrast to dia-
lyzing oligodendrocytes with 20 mM glucose, loading of astro-
cytes did not significantly influence CAP decline during EGD; a
partial rescue of CAP activity during EGD was observed in only
one of ten experiments (Figure 2A; n = 10, N = 6, p = 0.245).
It has been reported that slightly elevated extracellular K+
concentrations ([K+]e) can stimulate astrocytic glucose con-
sumption, glycogen mobilization, and lactate depletion from
astrocytes in tissue slices (Hof et al., 1988; Sotelo-Hitschfeld
et al., 2015). We therefore repeated the experiments in a bathing
solution with [K+]e lowered from 5 to 2.5 mM. In only two of ten
experiments, there was a moderate prevention of CAP loss dur-
ing EGD after astrocyte glucose loading, but the mean of the
normalized CAP area during EGD did not significantly differ
in comparison with experiments performed at elevated [K+]e
(p = 0.201; Figure S2).
Biocytin Injection into OligodendrocytesMainly Spreads
into a Network of Coupled Oligodendrocytes
The panglial network of astrocytes and oligodendrocytes in the
corpus callosum has so far been characterized only in young
(10–25 days old) mice (Maglione et al., 2010) but not in older
mice as used in our study. We analyzed the extent of coupling
in 18 slices from five animals (28–35 days old). PLP-GFP-
expressing oligodendrocytes close to the midline in the corpus
callosum (Figure 3) were dialyzed with a pipette solution contain-
ing biocytin for 20 min. Slices were subsequently fixed. In 16 of
18 slices, we found networks consisting of 22.5 ± 3.3 coupled
cells on average, and the tracer spread up to 360 mm along the
longitudinal axis (195 ± 19 mm, n = 16). For further characteriza-
tion of the networks, Olig2 and GFAP antibodies were used to
identify oligodendrocytes andastrocytes, respectively. Figure 3B
(left column) shows a typical example of a coupled network that
was filled via an oligodendrocyte. The biocytin-Cy3-stained cells
had the typical morphology of oligodendrocytes, with their cell
bodies arranged like a ‘‘rope of pearls’’ and their processes
aligned in parallel with axons. The networks were usually oval
shaped, with the longitudinal axis oriented in parallel to theCell Reports 22, 2383–2394, February 27, 2018 2385
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Figure 2. Glucose Loading of Oligodendrocytes but Not of Astrocytes Can Sustain Axonal Firing during EGD
GFP-positive oligodendrocytes or mRFP-positive astrocytes in the corpus callosum of a PLP-GFPxhGFAP-RFP transgenic mouse were preloaded with 20 mM
glucose before recording of CAPs.
(A) Top: averaged traces for CAP progression during 10 min EGD (glut-) and reperfusion at 36C without (black) or with preloading of glucose in an oligoden-
drocyte (green) or astrocyte (red). Bottom: scatterplot illustrates the normalized CAP areas at 16 min (as indicated by the red square in the top graph), shortly
before reperfusion with glucose-containing ACSF. Glucose loading via oligodendrocytes could significantly sustain CAPs during aglycemia, whereas glucose
loading via astrocytes prevented CAP loss in one of ten experiments (control without preloading, n = 37, N = 23; oligodendrocytes + glucose, n = 14, N = 10;
astrocytes + glucose, n = 10, N = 6; Kruskal-Wallis test, p < 0.05, black line represents the mean).
(B) The inset shows the typical current profile of an oligodendrocyte (left) and astrocyte (right) clamped at 70 mV in response to 10 de- and hyperpolarizing
voltage steps. Only cells that displayed a series resistance of %125% of the initial value after 20 min of dialysis were included for the following analysis. The
graphs in the middle show the averaged current densities plotted against the corresponding voltages of both cell types at the start and the end of the 20 min
dialysis period (black, 0 min; green, 20 min). The bottom graphs compare the membrane capacitance (Cm) and membrane resistance (Rm) of oligodendrocytes
and astrocytes at the start and the end of the dialysis. No significant differences were observed in either comparison (oligodendrocyte, n = 21, N = 7; astrocyte,
n = 4, N = 4; t test, p > 0.05). The number of experiments is indicated in the bars. Error bars reflect SEM.axonal processes (Figure 3B). In some instances, the biocytin
also traced the oligodendrocyte processes. Interestingly, the
oligodendroglial markers labeled only a subpopulation of the
coupled cells; Olig2, a transcription factor expressed by cells
of the oligodendrocytic lineage (Trotter et al., 2010), labeled
34.8% ± 4.9% (108 of 360) of biocytin-filled cells, and 35.1% ±
5.8% (134 of 360) of the coupled cells expressed the PLP
transgene. The two populations overlapped only partly (80 of
360 cells expressed both Olig2 and PLP-GFP). Nevertheless,
because of their morphology and typical arrangement, we
conclude that the networks consist mainly of oligodendrocytes.
GFAP labeling was rarely found in the biocytin-positive cells,
indicating that astrocytes were either excluded from the net-
works that were filled via an oligodendrocyte, or were not labeled
by GFAP.
To obtain an approximate estimate of the ratio of oligodendro-
cytes to astrocytes at the midline region of the corpus callosum,
we quantified PLP-positive and mRFP-positive cells, based on
the intrinsic fluorescence of the two transgenes. We analyzed
15 coronal sections of anterior corpus callosum of N = 3 dou-
ble-transgenic mice and found 59.8 ± 2.2 PLP-GFP-positive2386 Cell Reports 22, 2383–2394, February 27, 2018cells and 7.6 ± 0.3 GFAP-mRFP-positive cells on average per
given volume. This corresponds to a ratio of 88.7% oligodendro-
cytes and 11.3% astrocytes (Figure 3A). Although we are aware
that the transgenes do not label the entire oligodendrocyte and
astrocyte population (Fuss et al., 2000), and themRFP transgene
sometimes shows a mosaic-like expression pattern, our esti-
mate is in the same range as reported for the anterior CC of
rats (Reyes-Haro et al., 2013).
Because our observations suggest differences in astrocyte-
axonal metabolic coupling in corpus callosum compared with
optic nerve, we performed GFAP immunostaining in coronal
sections of anterior corpus callosum and in longitudinal optic
nerve sections to compare the density and cytoarchitecture of
GFAP-positive structures. In the corpus callosum, GFAP-
positive astrocytes are scattered throughout the tissue and
appear as individual, fibrous-like cells with processes of irregular
caliber traversing mostly parallel to the axons, with endfeet
contacting the blood vessels (Figure 3E). In contrast, in the optic
nerve GFAP immunolabeling reveals a dense network of pro-
cesses that appear knotted and irregular in shape (Figure 3E)
and confirm what Sun et al. (2009) reported for the optic nerve
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Figure 3. Appearance of Coupled Glial Networks in the Corpus Callosum and Difference in Astrocyte Density Compared with Optic Nerve
(A) Maximum intensity projection of a z stack of confocal images demonstrates the distribution of genetically labeled oligodendrocytes and astrocytes in the
medial corpus callosum (CC) of a PLP-GFPxhGFAP-mRFP transgenic mouse. Bar denotes 100 mm. Pie chart demonstrates the percentage of PLP-GFP-positive
versus hGFAP-mRFP-positive cells in native coronal slices near the midline of the corpus callosum averaged from n = 15 slices with duplicate to triplicate values
(N = 3).
(B) Projection of z stack images of a glial network filled with biocytin via an oligodendrocyte in a PLP-GFP transgenic mouse. Upper image shows biocytin
visualized with streptavidin Cy3; below is an Olig2 staining of the same area and the PLP-GFP signal. In the merged image (overlay), biocytin is displayed in
magenta; both PLP-GFP (green) and Olig2 (blue) are expressed only by a subpopulation of filled cells. Note the ‘‘rope of pearls’’ arrangement of the cell bodies;
biocytin also fills oligodendrocyte processes running in parallel to axons. Bar denotes 50 mm.
(C) Projection of z stack images of a glial network filled with biocytin via an astrocyte in a GFAP-mRFP mouse. Upper image shows biocytin visualized with
streptavidin Cy2, below Olig2 staining of the same area, and the mRFP signal. In the overlay, biocytin is displayed in green, mRFP in red, and Olig2 in blue. The
biocytin-filled network contains mRFP-expressing cells and Olig2-positive cells, cells expressing both markers (arrowheads), and cells expressing none of the
markers. Bar denotes 50 mm.
(D) Quantification of network size and horizontal spread of biocytin either filled via individual oligodendrocytes (green) or astrocytes (red) in transgenic animals as
mentioned above. Network size is highly variable but on average not significantly smaller when filled via astrocytes; tracer does not spread as far when filled via
astrocytes. *p < 0.05 (Student’s two-tailed t test). In total we injected oligodendrocytes in 18 slices from N = 5 PLP-GFP transgenic mice and astrocytes in
12 slices from N = 4 GFAP-mRFP mice. Error bars reflect SEM.
(E) Coronal sections of anterior corpus callosum and longitudinal sections of the optic nerve were immunolabeled for GFAP (white). Projection images of 12 mm
z stacks show the cytoarchitecture and density of GFAP-positive structures. Green, PLP-GFP transgene expression; blue, DAPI. Bars denote 25 mm. Error bars
reflect SEM.
(F) Percentage area of coverage by GFAP was analyzed using ImageJ as described. Number indicates number of slices analyzed (***p = 0.004).
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head. Astrocytic perikarya can hardly be recognized. For a quan-
titative comparison, we determined the area covered by GFAP-
positive structures in projection images of 12-mm-thick z stacks
that had been obtained from labeled sections of six animals,
using identical gain and offset settings. Projection images were
binarized in ImageJ (without previous adjustments of contrast
and brightness) by using identical thresholding settings for all
images, and area coverage of GFAP-positive pixels was
measured in five to six random frames per binarized image. In
optic nerve sections (n = 13), the GFAP-covered area was
27.8% ± 2.9% of the total area, while in corpus callosum sec-
tions (n = 10) it was only 9.5% ± 0.6% (p = 0.004, two-tailed
t test; Figure 3F), indicating a much higher density of GFAP-pos-
itive structures in the optic nerve.
Biocytin-Filled Astrocytes in the Corpus Callosum
Couple to Astrocytes and Oligodendrocytes
When biocytin was loaded via mRFP-positive astrocytes, we
also observed a large heterogeneity between the individual
dye-filling experiments, with regard to both network size and
tracer spread. However, on average, astroglial coupled networks
tended to be more rotund, though spreading of the dye into
longitudinal processes was observed as well. Filling via astro-
cytes (n = 12, N = 4) revealed coupled networks in ten slices,
with 13.2 ± 2.5 coupled cells on average. However, the differ-
ence compared with the oligodendrocyte networks (see above)
was not significant (Student’s two-tailed t test, p = 0.058; Fig-
ure 3D). An example of a coupled network that was filled via an
mRFP-positive astrocyte in the midline region of the corpus cal-
losum of a GFAP-mRFP transgenic animal is shown in Figure 3C.
More than one quarter (27.5% ± 4%) of the cells in the networks
were immunolabeled for Olig2, whereas 44.4% ± 11.2% (53 of
132 cells) of the biocytin-loaded cells expressed the transgene
marker GFAP-mRFP. GFAP immunolabeling was found in 8%
of the cells in the networks (not shown). We assume that
mRFP-expressing cells within the filled networks are mostly as-
trocytes and that the number of astrocytes in the networks might
rather be underestimated, as both the transgene and GFAP may
not be expressed by all astrocytes, and the antibodies might not
penetrate deeply enough to reach all biocytin-filled cells in
deeper levels of the slice. The dye-loading experiments suggest
that the networks, when loaded via an astrocyte, contain a higher
proportion of astrocytes. Some cells in the networks are immu-
nolabeled for Olig2, and biocytin diffuses into the longitudinal
processes aligned with the axons, indicating that
oligodendrocytes are also part of the network. The longitudinal
extent of biocytin diffusion was smaller when astrocytes were
dye-loaded (126 ± 11 mm compared with 195 ± 19 mm in net-
works loaded via oligodendrocytes; Student’s two-tailed t test,
p = 0.017, Figure 3D). Surprisingly, about one third of the
mRFP-positive cells (15 of 53) were also labeled for Olig2 (Fig-
ure 3C, arrowhead). Cells with such unique immunohistochem-
ical properties have been abundantly found in thalamic panglial
networks (Griemsmann et al., 2015). In conclusion, regardless
of whether they were filled via oligodendrocytes or astrocytes,
the coupled glial networks in the corpus callosum of mice aged
28–35 days are heterogeneous in size, as reported before for
younger animals (Maglione et al., 2010).2388 Cell Reports 22, 2383–2394, February 27, 2018Glucose Loading of Oligodendrocytes in Cx47 Knockout
Mice Does Not Prevent CAP Loss during EGD
To assess if inter-oligodendrocyte coupling is important for traf-
ficking of glucose and metabolic support of axons, we used the
Cx47-deficient mouse line, in which the size of coupled oligoden-
drocyte networks is markedly reduced, as shown for mice aged
10–15 days (Maglione et al., 2010). Oligodendrocytes were iden-
tified by their green fluorescence, as the Cx47-coding region was
replaced by the cDNA encoding EGFP (Odermatt et al., 2003).
Dialysis of 20mMglucose into oligodendrocytes for 20min could
prevent CAP loss during EGD in none of the experiments in Cx47
knockout (Cx47KO) animals, and the mean of the normalized
CAP area at 16 min did not differ significantly in comparison
with the control (Figure 4A; control 0.114 ± 0.058, oligodendro-
cyte filling 0.141 ± 0.046, n = 8 each, N = 5 animals each, p =
0.902). The passive membrane properties of oligodendrocytes
in the Cx47KO mice did not significantly change in the course
of the 20 min dialysis, indicating that the network composition
was not altered (Figure 4B). Dye-filling experiments of slices
from Cx47KO mice revealed significantly smaller coupled net-
works regarding the number of coupled cells (12.7 ± 2.2 versus
22.5 ± 3.3 in wild-type, p = 0.048). In Cx47KO animals, 29% of in-
jected oligodendrocytes did not show any dye spread to adjacent
cells (compared with 11% in wild-type). The tracer spread along
the longitudinal axis was on average significantly smaller in
Cx47KO animals (112 ± 20 mm, n = 12, N = 6 animals) compared
withwild-type (195± 19 mm, n = 16, N = 5; p = 0.0059 in two-tailed
t test; Figures 4C and 4D).
CAP Activity Can Partly Be Rescued by Dialysis of
Oligodendrocytes with 40 mM L-Lactate during EGD
Wenext tested whether lactate can also generate a rescue effect
when loaded into an oligodendrocyte prior to EGD. Interestingly,
dialysis with 20 mM L-lactate did not significantly affect the loss
of CAP activity during EGD. We next infused 40 mM lactate,
because one glucose molecule can generate two molecules of
lactate, and observed a partial prevention of the CAP decline
during aglycemia (Figure 5). Although the effect was not as
strong as that achieved by glucose, after loading 40 mM lactate,
there was still someCAP activity left at 16min comparedwith the
control without preloading any metabolite. Mean values of the
normalized CAP area were 0.119 ± 0.028 for 40 mM L-lactate
(n = 14, N = 7) and 0.021 ± 0.004 for control (n = 37, N = 23,
p = 0.024). Preloading with 20 mM mannitol, 20 mM L-lactate,
or 20 or 40 mM pyruvate did not affect the CAP decline during
10 min EGD. As a negative control, non-metabolizable D-lactate
(20 mM) also did not prevent CAP loss. The passive membrane
properties of oligodendrocytes during and after clamping and
during dialysis of intracellular solution with 40 mM L-lactate
were not significantly altered by the procedure (Figure S4). As
a control, dye-filling experiments of oligodendrocytes with intra-
cellular solution containing 40 mM L-lactate or 10 mM glucose
(equimolar to external glucose concentrations) did not reveal sig-
nificant differences in the average number of coupled cells and
dye spread, indicating that neither the high intracellular lactate
nor the increased glucose concentration affect coupling and
the size of glial networks as quantified by our method (Figures
S3 and S5). In summary, although infusion of high lactate into
A B
C D
Figure 4. Glucose Loading of Oligodendro-
cytes in Cx47KO Mice Cannot Sustain
Axonal Firing during EGD
Oligodendrocytes in the corpus callosum of
Cx47KO transgenic mice were preloaded with
20 mM glucose before recording CAPs as
described.
(A) Top: averaged traces for CAP progression dur-
ing 10 min of EGD (glut-) and reperfusion at 36C
without (black) or with preloading of oligodendro-
cytes (blue). Bottom: scatterplot of normalizedCAP
area at 16 min (as indicated in the top graphic)
shortly before reperfusion. The CAP loss cannot be
prevented by dialyzing oligodendrocytes with
glucose in thismouse line (n = 8 experiments, N = 6,
for control or 20 mM glucose; Kruskal-Wallis test,
p > 0.05, black line represents the mean).
(B) The top panel shows the typical current profile
of an oligodendrocyte clamped at 70 mV (left) in
response to 10 de- and hyperpolarizing voltage
steps (right) in a slice from a Cx47KO mouse. The
graph in the middle shows the averaged current
densities plotted against the corresponding volt-
ages at the start and the end of the 20 min dialysis
(black, 0 min; green, 20 min). No significant
differences were observed at any given voltage
step. The bottom graphs compare the membrane
capacitance (Cm) and membrane resistance (Rm)
of oligodendrocytes at the start and the end of the
dialysis, respectively. No significant differences
were observed in either comparison (t test, p >
0.05). The number of experiments is indicated at
the bottom of the bar graphs (n = 9, N = 5 for each
condition). Error bars reflect SEM.
(C) Examples of glial coupled networks (maximum
intensity projection of z stacks of confocal images)
after filling an oligodendrocyte with biocytin from
wild-type (WT)orCx47KOmice.Bardenotes50mm.
(D) Quantification of glial networks. Scatterplots show average number of coupled cells in networks from Cx47KO mice compared with WT (*p = 0.0418, t test).
Average tracer spread as defined by the largest distance between two somata of the coupled network (**p = 0.0059, t test). Percentage of coupled networks
observed in wild-type and Cx47KO mice. We analyzed n = 18, N = 5 wild-type, and n = 14 slices, N = 6 Cx47KO mice. Error bars reflect SEM.oligodendrocytes can partially prevent the loss of CAPs, glucose
filling was most efficient.
Simultaneous Disruption of Both Glucose and
Monocarboxylate Transport Inhibits the Prevention of
CAP Loss Seen after Glucose Loading of
Oligodendrocytes
To further characterize the mechanisms involved in the preven-
tion of EGD-induced CAP loss due to preloading of glucose
into oligodendrocyte networks, we tested the effect of inhibited
metabolite transport. We blocked MCTs, which are able to
transport monocarboxylates, using 4-CIN (a-cyano-4-hydroxy-
cinnamic acid; 200 mM) or AR-C155858 (1 mM). The latter
specifically inhibits MCT1 and MCT2, the isoforms expressed
by oligodendrocytes and neurons, respectively, whereas 4-CIN
acts on all MCT subtypes. We also used Stf31 to inhibit
glucose transporter GLUT1, which is specifically expressed by
oligodendrocytes and astrocytes, and GTI2, which specifically
blocks GLUT3 on axons. Ten minute application of 4-CIN,
AR-C155858, or Stf31 in the presence of external glucose did
not significantly alter CAPs (not shown). The combined applica-tion of AR-C155858 and Stf31 or the single application of GTI2
lead to a moderate drop of CAPs of about 20% during the appli-
cation period (Figure 6A). We then studied the effect of the
inhibitors on the CAP decline during EGD after filling an oligoden-
drocyte with glucose. 4-CIN significantly reduced the CAP am-
plitudes and thus abolished the rescue effect of glucose dialysis
(n = 11, N = 5). AR-C155858 (n = 9, N = 4) and Stf31 (n = 17, N = 9)
alone did not significantly affect the prevention of CAP loss.
A combined application of AR-C155858 and Stf31 or the appli-
cation of GTI2, however, completely abolished the effect of
glucose loading on CAP loss; CAPs dropped as in the control
without preloading glucose into oligodendrocytes (AR-
C155858 and Stf31, n = 13, N = 5 animals; GTI2, n = 5, N = 2
animals; Figure 6B). Thus we conclude that both glucose and
lactate transporter activity is required to sustain CAP activity dur-
ing EGD when oligodendrocytes are dialyzed with glucose.
DISCUSSION
In white matter, specialized mechanisms for energy delivery
are required to maintain axonal function. The axon and itsCell Reports 22, 2383–2394, February 27, 2018 2389
AB
Figure 5. CAP Loss Can Partially Be Prevented during Aglycemia by
Filling Oligodendrocytes with Glucose or Equimolar L-Lactate
Top: averaged traces for CAP progression during 10 min of EGD (glut-) and
reperfusion at 36Cwithout (black) or with preloading of oligodendrocytes with
20 mM glucose (green) or 40 mM L-lactate (blue). Bottom: scatterplots illus-
trate the normalized CAP area at 16 min (as indicated by the red square in the
top graph) shortly before reperfusion. The CAP loss can be significantly
prevented only by dialyzing oligodendrocytes with 20 mM glucose or 40 mM
L-lactate (40 mM to consider carbon equivalent of 20 mM glucose). Neither
20 mM mannitol, 20 or 40 mM pyruvate, nor the non-metabolizable variant
D-lactate prevented CAP loss; control n= 37 (N = 23), 20 mM mannitol n = 6
(N = 3), 20 mM glucose n = 14 (N = 10), 20 mM L-lactate n = 10 (N = 7), 40 mM
L-lactate n = 14 (N = 7), 20 mMD-lactate n = 15 (N = 9), 20 mM pyruvate n = 10
(N = 9), 40 mM pyruvate n = 10 (N = 6); Kruskal-Wallis test, p < 0.05 (black line
represents the mean).enwrapping myelin sheath form a functional unit that enables the
exchange of metabolites between oligodendrocytes and axons
to meet the high energy demand for action potential generation
(Simons and Nave, 2015). In the present study, we investigated
axonal activity in the corpus callosum and provide evidence for
glucose supply from oligodendrocytes to axons via gap
junction-coupled glial networks.
One of our major findings is that in the corpus callosum, CAPs
declined within a few minutes after glucose deprivation and,
surprisingly, that the replacement of external glucose by
L-lactate or pyruvate did not maintain axonal function. Studies
of the mechanisms of energy delivery to axons in white matter
have so far mostly been performed in the optic nerve, where
the transfer of lactate is instrumental to fuel axons (Brown
et al., 2003; F€unfschilling et al., 2012). Furthermore, in the
absence of glucose and lactate, CAPs in the optic nerve can2390 Cell Reports 22, 2383–2394, February 27, 2018be recorded for about 30 min during aglycemia before they fail,
indicating that mechanisms of energy storage and supply are
different in these brain regions. Indeed, fundamental morpholog-
ical differences between these two white matter tracts have
already been described, particularly regarding the axonal myeli-
nation level. Axons in the optic tract are almost completely
myelinated (Honjin et al., 1977), whereas myelination in the
corpus callosum reaches only 30%–40% and is therefore
comparatively sparse (Kim et al., 1996; Mack et al., 1995; Stur-
rock, 1980). Our immunohistochemical study adds information
about the cytoarchitecture of the GFAP-positive astrocytic
network in these brain regions. However, it must be noted that
there might be overseen GFAP-negative astrocytes and that
our quantitative comparison could not yield measures for cell
density but rather GFAP-targeted fluorescence signals. Still, it
became obvious that the density and spatial arrangement of
astrocytes in corpus callosum and optic nerve are different. It
is tempting to speculate that these differences could be indica-
tive of a different contribution of astrocytes to the metabolite
supply to axons in optic nerve and corpus callosum. Indeed, as-
trocytes represent the energy storage elements in the brain
(Ransom and Fern, 1997; Saab et al., 2013), and in mouse optic
nerve, astrocytic glycogen stores were shown to be important to
maintain axonal activity. Breakdown of astrocytic glycogen to
lactate and lactate shuttling via MCT1 from oligodendrocytes
to axons are essential to fuel optic nerve axons during increased
neuronal activity and maintain their activity under aglycemic
conditions (Brown et al., 2005; F€unfschilling et al., 2012). Thus,
in theory, a low glycogen storage capacity of the astrocytic
network of the corpus callosum would explain the more rapid
decline in the CAP during glucose depletion in our preparation
compared with the optic nerve. However, it does not explain
the observation that exchange of glucose by L-lactate does
not maintain axonal function in the corpus callosum. We there-
fore conclude that mechanisms of metabolite transport from glial
cells to axons in the corpus callosum differ from those in the
optic nerve. Indeed, Oe et al. (2016) revealed brain region-
dependent differences in glycogen accumulation and suggest
metabolic heterogeneity of astrocytes.
In the classic optic nerve preparation, one end of the nerve is
stimulated while the activity is recorded at the other end using
suction electrodes (Brown et al., 2001). Such an arrangement
is not possible in the corpus callosum, and we therefore used
acute brain slices, local stimulation, and field potential record-
ings. This restricted our experiments to a much smaller volume
that is within the range of glial networks as determined by bio-
cytin; typically they extend about 200 mm (see Figure 3D). Using
a patch-clamp pipette, we then loaded glucose into a single
oligodendrocyte in the corpus callosum and found that it can
sustain part of the activity of callosal axons when external
glucose is withdrawn. Although the infused glucose concentra-
tion of 20 mM is far above physiological concentrations of
0.5–1 mM (Saab et al., 2016), such a concentration will most
likely only be seen in the soma of the initially patched cell.
Glucose concentrations in coupled oligodendrocytes and at
the oligodendrocyte compartments close to the axon are hard
to predict but will surely be magnitudes lower than 20 mM
because of limited diffusion. However, to explain the observed
AB
Figure 6. CAP Loss Prevention by Glucose-Loaded Oligodendro-
cytes Can Be Blocked Only by Combined Disruption of Glucose and
Monocarboxylate Transport
(A) Averaged traces for CAP progression during 10 min blocker application
while continuously perfusing with glucose-containing ACSF at 36Cwith either
a combination of Stf31 and AR-C155858 (magenta, n = 4, N = 2) or GTI2 (dark
gray, n = 6, N = 2). Neither application of 4-CIN, AR-C155858, nor STF-31 led
to a reduction or an overshoot of the measured CAPs.
(B) Pharmacological blockers 4-CIN (200 mM), AR-C155858 (1 mM), Stf31
(5 mM), or GTI2 (5 mM) were applied simultaneously during EGD. Scatterplot
illustrates the normalized CAP area at 16 min (i.e., shortly before glucose re-
perfusion). CAP loss prevention by previously glucose-filled oligodendrocytes
can be abolished only by using the unspecific MCT blocker 4-CIN, by the
combination of both specific MCT and GLUT blockers, or by the GLUT3
blocker GTI2. AR-C155858 alone does not affect CAP loss prevention by
glucose pre-loading, suggesting that both lactate and glucose are transported
to the axons; control n = 37 (N = 23), glucose filled n = 14 (N = 10), glucose
filled + 4-CIN application n = 11 (N = 5), glucose filled + AR-C155858 appli-
cation n = 9 (N = 4), glucose filled + Stf31 application n = 17 (N = 9), glucose
filled + Stf/AR-C application n = 13 (N = 5); glucose filled + GTI2 application
n = 10 (N = 5); Kruskal-Wallis test, significant when p < 0.05 (black line rep-
resents the mean).rescuing effect during external glucose deprivation, we suppose
that glucose levels in the preloaded glial networks are higher
compared with networks that were not infused with glucose.
Assuming that glucose diffuses at least as well as the larger
molecule biocytin, which readily spreads within a coupled glial
network in a 200 mm range, it is most likely that glucose spreads
in a similar fashion. The variability in the extent of CAP mainte-
nance during aglycemia after oligodendrocyte filling can likely
be explained by the considerable variation in the size of the
loaded glial networks after injection into a single oligodendro-
cyte. This hypothesis is supported by experiments on Cx47KO
brain slices in which the smaller glial networks did not support
the function of axons during aglycemia. Furthermore, as shown
here, longitudinal tracer spread was lower when astrocyteswere injected compared with oligodendrocytes. Moreover astro-
cytes per se have less direct contact to the axons. These factors
may explain why glucose loading of astrocytes failed to rescue
axonal activity during aglycemia. However, this observation
does not necessarily imply that there is no metabolite support
from astrocytes to axons in the corpus callosum at all. It rather
indicates that in our experimental paradigm, the rescue of axonal
activity during aglycemia largely depends on the integrity of the
glucose-loaded oligodendrocyte network between stimulation
and field potential recording electrodes. In addition to the
discussion above, it is remarkable that glucose application to a
single oligodendrocyte reduced the external glucose depriva-
tion-induced loss of CAP amplitude on average to only 40%–
50% of the initial control (Figure 2). This percentage is in the
range of the population of CAP size from unmyelinated fibers
in the corpus callosum (Crawford et al., 2009), and it supports
the hypothesis that glucose filling of oligodendrocytes will partic-
ularly support the proportion of myelinated axons in our
experiments. Unfortunately, with a distance of 300 mm between
stimulation and recording electrode, we could not discriminate
between the myelinated and unmyelinated CAP component.
In the present study, we also aimed to identify which metabo-
lite transporters are involved in the energy supply from oligoden-
drocytes to axons. We focused on members of the glucose
transporter (GLUT) family as well as on members of the mono-
carboxylate transporter family (MCT) that co-transport H+ and
lactate. Although there is evidence that neurons generally prefer
lactate over glucose to fuel their energy metabolism (Tekko¨k
et al., 2005), glucose can also be directly taken up and used
by neurons in an activity-dependent manner (Lundgaard et al.,
2015). Glucose uptake into cells is achieved by a family of inte-
gral membrane transporter proteins, the GLUTs. Neurons
express primarily GLUT3, whereas GLUT1 is highly enriched in
astrocytes and oligodendrocytes (Vannucci et al., 1997; Yu
and Ding, 1998). In the optic nerve, GLUT1 was subcellularly
detected by immunogold labeling in the myelin sheaths, outer
tongue, and paranodal loops of myelinating oligodendrocytes
(Saab et al., 2016). GLUT3 is found predominantly in cell pro-
cesses like the axons (Magnani et al., 1996) and exhibits a lower
Km for glucose uptake and a 5-fold higher capacity for glucose
uptake than its glial counterpart GLUT1 (Simpson et al., 2008).
This is one possible explanation for the fast recovery of CAPs
after aglycemia, as axons might directly take up glucose from
the bath and thereby quickly recover their ability to generate
action potentials. To explain our experimental aglycemia-rescue
paradigm, we first hypothesized that glucose is released from
pre-filled oligodendrocytes via GLUT1-mediated export and
subsequently imported into the axons and axonal GLUT3-medi-
ated import. Indeed, inhibition of GLUT3 completely abolished
CAP rescue during aglycemia; however, in the presence of the
GLUT1 inhibitor Stf31, glucose loading of oligodendrocytes still
prevented the CAP decline, indicating that mechanisms of
energy supply are more complex and involve other elements.
In addition, extrusion of glucose via GLUT1 would require
glucose-6-phosphatase activity in oligodendrocytes to regen-
erate glucose after its rapid phosphorylation by hexokinase
upon entering the cell. Although glucose-6-phosphatase activity
has been shown for cortical oligodendrocytes (Al-Ali andCell Reports 22, 2383–2394, February 27, 2018 2391
Robinson, 1981) its expression in callosal oligodendrocytes
remains to be proved. One surprising result was that loading of
single oligodendrocytes with high concentrations of lactate
(40 mM) did, like glucose, support axonal CAPs during aglyce-
mia. This indicates lactate transport between neurons and
oligodendrocytes. One reason for a less effective rescuing effect
by loading lactate compared with glucose into glial networks
may be that the diffusion of lactate into the oligodendrocyte pro-
cesses is hampered by its negative charge and electrostatic
interactions with numerous binding sites in the cytoplasm. Inhi-
bition of the oligodendroglial MCT1 and axonal MCT2 lactate
transporters during aglycemia did not abolish glucose support
from oligodendrocytes. However, the combined blockade of
oligodendroglial lactate and glucose export using MCT1/2 and
GLUT1 inhibitors completely abolished the oligodendroglial
support to axons during aglycemia, indicating that there must
be both glucose and lactate supply from oligodendrocyte to
axons via MCTs and GLUT1. Also, it remains elusive why
blockade of axonal GLUT3 successfully prevented metabolic
support from oligodendrocytes during aglycemia, and the exper-
iments performed in the present study cannot give a conclusive
answer to that question. We therefore conclude that the panglial
network in the corpus callosum is important for metabolic sup-
port of axons, and that oligodendroglial supply of lactate and
glucose via MCT1 and GLUT1 must be a major component of
its underlying mechanism.
EXPERIMENTAL PROCEDURES
Animals and Handling
All procedures involving handling of living animals were performed in
accordance with the German Animal Protection Law and were approved by
the Regional Office for Health and Social Services in Berlin (Landesamt f€ur
Gesundheit und Soziales, Berlin, Germany, approval T0014/08, X9023/12).
Transgenic PLP-GFP (Fuss et al., 2000) and GFAP-mRFP (Hirrlinger et al.,
2005) reporter mice and Cx47-deficient mice (Tress et al., 2012) of either
sex, aged 28–35 days, were used for the studies. For preparation of acute brain
slices, mice were sacrificed by cervical dislocation as described by (Maglione
et al., 2010) and as detailed in Supplemental Experimental Procedures. For
immunohistochemistry, mice were sacrificed by deep anesthesia and perfu-
sion fixation. All efforts were made to minimize suffering.
Recording of CAPs and External Glucose Deprivation
Extracellular field potentials were recorded at room temperature or 36C in
freshly prepared brain slices that were placed in a recording chambermounted
on an upright microscope as previously described (Richter et al., 2014). Stim-
ulation and recording electrodes (impedance 100–500 kU) were placed in the
corpus callosum both about 150 mm lateral of the midline (Figure 1A). The stim-
ulation protocol and analysis of the evoked CAP is detailed in Supplemental
Experimental Procedures.
For EGD experiments at 36C, the perfusion with glucose-containing ACSF
was switched for 10min to glucose-free ACSF, before the slicewas reperfused
with glucose-containing ACSF for 30min. In experiments at room temperature,
the EGD period lasted for 55 min. In some experiments, glucose was replaced
by L-lactate, D-lactate, pyruvate, or mannitol. Pharmacological blockers of
lactate and glucose transporters 4-CIN, AR-C155858, Stf31, and GTI2 and
were applied via the bath perfusion.
Patch-Clamp Recordings
Oligodendrocytes (PLP-GFP) in the corpus callosum were identified by their
GFP fluorescence and astrocytes in hGFAP-mRFP mice by their RFP fluores-
cence, using a 603 water-immersion objective. For recording and metabolic2392 Cell Reports 22, 2383–2394, February 27, 2018loading, a patch pipette was pulled from borosilicate glass and filled with a
HEPES-buffered intracellular solution to which we added 20 mM glucose,
20 mM mannitol, 20 mM L-lactate, 40 mM L-lactate, 20 mM D-lactate,
20 mM pyruvate, or 40mM pyruvate. Sulforhodamine B (10 mg/mL) was added
to the pipette solution for confirmation of intracellular access during the patch-
clamp experiment. The pipette resistance ranged from 4 to 7 MU. Cells were
selected close to the stimulation electrode ensuring that the stimulated axons
were in proximity to the potential glucose-filled panglial network. Cells were
dialyzed via the patch pipette for 20min prior to EGD to ensure that the metab-
olites spread into coupled cells of the panglial network. To confirm the cell
identity and vitality, membrane currents were recorded as described previ-
ously (Richter et al., 2014). Only cells that showed a series resistance %
125% at the end of the dialysis process compared with the start were taken
into account for the calculation of the membrane properties. After metabolite
loading and patch-clamp recording, the pipette was carefully removed from
the cell in order to disrupt the patch. Specifications and details of the analysis
of the recordings are given in Supplemental Experimental Procedures.
Dye-Coupling Experiments, Immunohistochemistry, and
Quantification
Characterization of coupled networks in the corpus callosum was performed
by dye filling, subsequent immunohistochemistry, and confocal microscopy
in acute brain slices of mice aged 28–35 days as previously described (Ma-
glione et al., 2010). GFAP immunohistochemistry on cryosections of corpus
callosum and optic nerve was done as described previously (Nolte et al.,
2001) with modifications. Details and information on quantification are given
in Supplemental Experimental Procedures.
Statistics
Resultswere statistically analyzed usingGraphPadPrismSoftware (LaJolla, CA
92037USA). If not otherwise stateddata areprovidedasmean±SEM;n refers to
the number of brain slices investigated and N to the number of animals. These
numbers are indicated in the figure legends and in the text. Data were tested
using Student’s two-tailed t test or the Kruskal-Wallis test. Differences were re-
garded as significant at *p < 0.05, **p < 0.01, ***p < 0.001, or ****p < 0.0001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at https://doi.org/
10.1016/j.celrep.2018.02.022.
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